Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29734579 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2RAB9ANPC1LMNAHPGD | |
| SCHEMBL11048017 | 0.83 | SMN1; SMN2 (0.40) | SMN1; SMN2RAB9ANPC1LMNAHPGD | |
| SCHEMBL4758376 | 0.74 | TSHR (0.32) | TSHR | |
| SCHEMBL4758985 | 0.73 | PPARD (0.39) | SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL8063043 | 0.72 | SMN1; SMN2 (0.41) | SMN1; SMN2RAB9ANPC1LMNAHPGD | |
| SCHEMBL5085699 | 0.72 | GRM4 (0.41) | SMN1; SMN2RAB9ANPC1LMNAHPGD | |
| SCHEMBL5088952 | 0.72 | TSHR (0.31) | TSHR | |
| SCHEMBL29734626 | 0.71 | MAOA (0.48) | ALDH1A1MAPT | |
| SCHEMBL29734622 | 0.71 | MAOA (0.48) | ALDH1A1MAPT | |
| SCHEMBL5088929 | 0.71 | MAOA (0.48) | ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12492275-B2 | Photo-curable compositions containing high refractive index monomers for use in 3D printing applications | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | claimed |
| US-20240052081-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2024-02-15 | — | — | US | claimed |
| EP-4028480-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2022-07-20 | — | — | EP | claimed |
| WO-2021048628-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2021-03-18 | — | — | WO | claimed |
| US-20050049376-A1 | High refractive index, uv-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY | 2005-03-03 | — | — | US | claimed |
| US-12492275-B2 | Photo-curable compositions containing high refractive index monomers for use in 3D printing applications | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| US-20240052081-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2024-02-15 | — | — | US | disclosed |
| EP-4028480-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2022-07-20 | — | — | EP | disclosed |
| WO-2021048628-A1 | PHOTO-CURABLE COMPOSITIONS CONTAINING HIGH REFRACTIVE INDEX MONOMERS FOR USE IN 3D PRINTING APPLICATIONS | ARKEMA FRANCE (FR) | 2021-03-18 | — | — | WO | disclosed |
| US-20080145545-A1 | METAL OXIDE AND SULFUR-CONTAINING COATING COMPOSITIONS, METHODS OF USE, AND ARTICLES PREPARED THEREFROM | CITIBANK, N.A., AS COLLATERAL AGENT | 2008-06-19 | — | — | US | disclosed |
| WO-2008073534-A1 | METAL OXIDE AND SULFUR-CONTAINING COATING COMPOSITIONS, METHODS OF USE, AND ARTICLES PREPARED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
| US-7271283-B2 | High refractive index, UV-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY (US) | 2007-09-18 | — | — | US | disclosed |
| EP-1512704-A1 | High refractive index, UV-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY (US) | 2005-03-09 | — | — | EP | disclosed |
| US-20050049376-A1 | High refractive index, uv-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY | 2005-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049376-A1 | High refractive index, uv-curable monomers and coating compositions prepared therefrom | MACF1, WASF2, THEM6 | SMN1; SMN2 3159/4885RAB9A 2801/4885NPC1 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.